Log in
/
English
Polski
Español
українська
Toggle navigation
Textbook
Sections
Diseases
Noninvasive Diagnostic Tests
Procedures
Signs and Symptoms
Trauma and Injuries
Acute and Critical Medical Care
Abbreviations
CME
GRADE
Chapters
Course
What’s New
Interviews
McMaster Perspective
Cardiology
Endocrinology
Gastroenterology
Hematology
ICU & Emergencies
Infectious Diseases
Nephrology
Neurology
Oncology
Respirology
Rheumatology
Toxicology
VTE
Other
Lectures
Refreshers
Articles
Resources
Editorial Board
Mobile
Sponsors
Diseases
Allergy & Immunology
Cardiovascular Diseases
Dermatology
Endocrinology
Fluids, Electrolytes, Acids, Bases
Gastroenterology
Geriatrics
Hematology
Infectious Diseases
Nephrology
Neurology
Palliative Care
Poisonings & Intoxications
Psychiatry
Respiratory Diseases
Rheumatology
Noninvasive Diagnostic Tests
Procedures
Signs & Symptoms
Trauma & Injuries
Acute & Critical Medical Care
Abbreviations
CME
GRADE
Log in
/
McMaster Textbook of Internal Medicine
Interviews
VTE
Assessing the risk of recurrent thrombosis and the Vienna Prediction Model
Assessing the risk of recurrent thrombosis and the Vienna Prediction Model
2015-06-05
James Douketis
See also
An association between novel oral anticoagulants, acute coronary syndromes, and the risk of myocardial infarction
Is there an association between novel oral anticoagulants, acute coronary syndromes, and the risk of myocardial infarction?
The optimal approach to anticoagulant treatment in patients with a high bleeding risk
What is the optimal approach to anticoagulant treatment in patients with a high bleeding risk? How should we estimate the bleeding risk and adjust anticoagulant treatment to the bleeding risk?
We would love to hear from you
Comments, mistakes, suggestions?
Send feedback
Social Media